Regis Healthcare (ASX:REG) Growth Rank: 10 (As of Jul. 16, 2026) — 67% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:REG Regis Healthcare Ltd ASX:REG
79 GF Score
Price A$6.00
GF Value A$10.53
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Regis Healthcare Growth Rank?

Regis Healthcare ASX:REG +1.35% 79 Growth Rank is 10 as of Jul. 16, 2026, which is 67% above its 10-year median of 6.00. GuruFocus rates ASX:REG with a GF Score™ of 79/100 and a GF Value™ of A$10.53 (Possible Value Trap). The stock has 4 warning signs investors should review.

Regis Healthcare has the Growth Rank of 10.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Regis Healthcare Growth Rank Related Terms

ASX:REG vs HCA, THC, DVA: Growth Rank Comparison

For the Medical Care Facilities subindustry, Regis Healthcare's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regis Healthcare Growth Rank vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Regis Healthcare's Growth Rank distribution charts can be found below:

* The bar in red indicates where Regis Healthcare's Growth Rank falls into.


ASX:REG
79GF Score
Regis Healthcare Ltd ASX:REG
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 10 mean?
Regis Healthcare (ASX:REG) has a Growth Rank of 10 as of Jul. 16, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Regis Healthcare and its competitors. This is 67% above median its historical median of 6.00. Over the past decade, Regis Healthcare's Growth Rank has ranged from 2.00 to 10.00.
Is Regis Healthcare's Growth Rank too high?
Regis Healthcare's current Growth Rank of 10 is 67% above median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 10.00. Overall, Regis Healthcare has a GF Score™ of 79/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Regis Healthcare's Growth Rank compare to HCA and THC?
Regis Healthcare's Growth Rank of 10 can be compared against companies in the Healthcare Providers & Services industry. Historically, Regis Healthcare's own Growth Rank has ranged from 2.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Healthcare Providers & Services company?
A good Growth Rank depends on the Healthcare Providers & Services industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Regis Healthcare and its competitors. Regis Healthcare's current Growth Rank is 10, which is 67% above median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regis Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Regis Healthcare (ASX:REG) is currently considered Possible Value Trap. The stock's GF Value™ is A$10.53, compared to a current price of A$6.00 — trading 43% below its estimated fair value. The current Growth Rank is 10, which is 67% above median its 10-year median of 6.00. Regis Healthcare's overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Regis Healthcare (ASX:REG), the current Growth Rank is 10 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Regis Healthcare (ASX:REG) Overvalued in 2026?

Based on GuruFocus' analysis, Regis Healthcare stock appears to be undervalued. The current stock price of A$6.00 is trading 43% below its estimated GF Value™ of A$10.53. GuruFocus considers Regis Healthcare to be Possible Value Trap.

Key valuation signals for ASX:REG:

  • Growth Rank: 10 (67% above median its 10-year median of 6.00)
  • GF Value™: A$10.53 vs. price of A$6.00 (43% below fair value)
  • GF Score™: 79/100 with 4 warning signs

No single metric tells the full story. See the ASX:REG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Regis Healthcare Business Description

Other Exchanges 06K1:Germany
Address 293 Camberwell Road, Level 2, Camberwell, Melbourne, VIC, AUS, 3124
Regis Healthcare is an Australian residential aged care operator providing accommodation and care for individuals who require high levels of support due to health or mobility issues. Residents are typically over 85 years old and are typified by dementia, palliative care, incontinence, and falls risk. Regis also operates smaller retirement village and home care businesses.
79GF Score

Get the complete analysis for ASX:REG

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$6.00
Price
A$10.53
GF Value